Samantha Budd Haeberlein

Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease

Samantha Budd Haeberlein, Paul Aisen, Frederik Barkhof et al. · The Journal of Prevention of Alzheimer s Disease · 2022 · 1.3K citations · Full text

Medicine, Neurology, Pharmacology +17

Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease

Stephen Salloway, Spyros Chalkias, Frederik Barkhof et al. · JAMA Neurology · 2021 · 584 citations · Full text

Medicine, Neurology, Pharmacology +16

Trial of Cinpanemab in Early Parkinson’s Disease

Anthony E. Lang, Andrew Siderowf, Eric A. Macklin et al. · New England Journal of Medicine · 2022 · 333 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial

Adam L. Boxer, Irfan Qureshi, Michael K. Ahlijanian et al. · The Lancet Neurology · 2019 · 141 citations

Pharmacy, Neurology, Pharmacotherapy +10

Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial

Tien Dam, Adam L. Boxer, Lawrence I. Golbe et al. · Nature Medicine · 2021 · 138 citations

Pharmacy, Neurology, Pharmacotherapy +6